ArticleFrontiers in neurology
Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).
Luisa Fofi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.